SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Fundamental Analysis
FRA:56S1 - Deutsche Boerse Ag - FR0013154002 - Common Stock - Currency: EUR
Overall 56S1 gets a fundamental rating of 5 out of 10. We evaluated 56S1 against 18 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of 56S1 get a neutral evaluation. Nothing too spectacular is happening here. 56S1 is valued quite expensive, but it does show an excellent growth. These ratings would make 56S1 suitable for growth investing!
1. Profitability
1.1 Basic Checks
56S1 had positive earnings in the past year.
56S1 had a positive operating cash flow in the past year.
Each year in the past 5 years 56S1 has been profitable.
In the past 5 years 56S1 always reported a positive cash flow from operatings.
1.2 Ratios
56S1 has a Return On Assets (2.46%) which is in line with its industry peers.
With a Return On Equity value of 5.14%, 56S1 perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
56S1 has a Return On Invested Capital of 4.36%. This is comparable to the rest of the industry: 56S1 outperforms 44.44% of its industry peers.
56S1 had an Average Return On Invested Capital over the past 3 years of 10.41%. This is above the industry average of 6.95%.
The last Return On Invested Capital (4.36%) for 56S1 is well below the 3 year average (10.41%), which needs to be investigated, but indicates that 56S1 had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.46% | ||
| ROE | 5.14% | ||
| ROIC | 4.36% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
1.3 Margins
The Profit Margin of 56S1 (7.15%) is better than 66.67% of its industry peers.
In the last couple of years the Profit Margin of 56S1 has declined.
56S1 has a Operating Margin (14.05%) which is comparable to the rest of the industry.
56S1's Operating Margin has declined in the last couple of years.
56S1 has a better Gross Margin (43.89%) than 66.67% of its industry peers.
In the last couple of years the Gross Margin of 56S1 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.05% | ||
| PM (TTM) | 7.15% | ||
| GM | 43.89% |
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 56S1 is creating some value.
The number of shares outstanding for 56S1 has been increased compared to 1 year ago.
Compared to 5 years ago, 56S1 has more shares outstanding
56S1 has a better debt/assets ratio than last year.
2.2 Solvency
56S1 has an Altman-Z score of 3.54. This indicates that 56S1 is financially healthy and has little risk of bankruptcy at the moment.
56S1 has a Altman-Z score of 3.54. This is in the better half of the industry: 56S1 outperforms 72.22% of its industry peers.
56S1 has a debt to FCF ratio of 5.03. This is a neutral value as 56S1 would need 5.03 years to pay back of all of its debts.
With a Debt to FCF ratio value of 5.03, 56S1 perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
56S1 has a Debt/Equity ratio of 0.72. This is a neutral value indicating 56S1 is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.72, 56S1 is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | 5.03 | ||
| Altman-Z | 3.54 |
ROIC/WACC0.56
WACC7.82%
2.3 Liquidity
A Current Ratio of 1.85 indicates that 56S1 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.85, 56S1 is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 1.14 indicates that 56S1 should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.14, 56S1 perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.14 |
3. Growth
3.1 Past
56S1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.91%, which is quite impressive.
56S1 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.19% yearly.
The Revenue has been growing slightly by 0.16% in the past year.
56S1 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.05% yearly.
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%
3.2 Future
The Earnings Per Share is expected to grow by 21.45% on average over the next years. This is a very strong growth
Based on estimates for the next years, 56S1 will show a quite strong growth in Revenue. The Revenue will grow by 10.39% on average per year.
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y21.45%
Revenue Next Year9.39%
Revenue Next 2Y9.85%
Revenue Next 3Y10.49%
Revenue Next 5Y10.39%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 40.51 indicates a quite expensive valuation of 56S1.
72.22% of the companies in the same industry are cheaper than 56S1, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.54. 56S1 is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 30.34, the valuation of 56S1 can be described as expensive.
Based on the Price/Forward Earnings ratio, 56S1 is valued a bit more expensive than 72.22% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.28, 56S1 is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.51 | ||
| Fwd PE | 30.34 |
4.2 Price Multiples
72.22% of the companies in the same industry are cheaper than 56S1, based on the Enterprise Value to EBITDA ratio.
56S1's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.9 | ||
| EV/EBITDA | 26.01 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
56S1's earnings are expected to grow with 24.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.69
PEG (5Y)9.66
EPS Next 2Y25.51%
EPS Next 3Y24.81%
5. Dividend
5.1 Amount
With a yearly dividend of 0.39%, 56S1 is not a good candidate for dividend investing.
56S1's Dividend Yield is slightly below the industry average, which is at 0.73.
Compared to an average S&P500 Dividend Yield of 2.40, 56S1's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
5.2 History
The dividend of 56S1 has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
32.84% of the earnings are spent on dividend by 56S1. This is a low number and sustainable payout ratio.
56S1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP32.84%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
FRA:56S1 (8/7/2025, 7:00:00 PM)
167.3
+1.4 (+0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners10.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.28B
Analysts77.78
Price Target242.86 (45.16%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.39% |
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP32.84%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.91%
Min EPS beat(2)7.63%
Max EPS beat(2)22.18%
EPS beat(4)2
Avg EPS beat(4)0.98%
Min EPS beat(4)-20.27%
Max EPS beat(4)22.18%
EPS beat(8)2
Avg EPS beat(8)-16.9%
EPS beat(12)2
Avg EPS beat(12)-16.88%
EPS beat(16)5
Avg EPS beat(16)-11.85%
Revenue beat(2)2
Avg Revenue beat(2)3.21%
Min Revenue beat(2)2.91%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)3.52%
Revenue beat(8)4
Avg Revenue beat(8)-1.35%
Revenue beat(12)4
Avg Revenue beat(12)-1.7%
Revenue beat(16)8
Avg Revenue beat(16)12.23%
PT rev (1m)2.49%
PT rev (3m)-0.39%
EPS NQ rev (1m)0.47%
EPS NQ rev (3m)4.79%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)2.75%
Revenue NQ rev (3m)1.34%
Revenue NY rev (1m)0.83%
Revenue NY rev (3m)0.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.51 | ||
| Fwd PE | 30.34 | ||
| P/S | 5.7 | ||
| P/FCF | 27.9 | ||
| P/OCF | 18.51 | ||
| P/B | 4.1 | ||
| P/tB | N/A | ||
| EV/EBITDA | 26.01 |
EPS(TTM)4.13
EY2.47%
EPS(NY)5.51
Fwd EY3.3%
FCF(TTM)6
FCFY3.58%
OCF(TTM)9.04
OCFY5.4%
SpS29.36
BVpS40.81
TBVpS-5.43
PEG (NY)1.69
PEG (5Y)9.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.46% | ||
| ROE | 5.14% | ||
| ROCE | 5.47% | ||
| ROIC | 4.36% | ||
| ROICexc | 4.84% | ||
| ROICexgc | 15.14% | ||
| OM | 14.05% | ||
| PM (TTM) | 7.15% | ||
| GM | 43.89% | ||
| FCFM | 20.42% |
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score7
Asset Turnover0.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | 5.03 | ||
| Debt/EBITDA | 4 | ||
| Cap/Depr | 95.85% | ||
| Cap/Sales | 10.35% | ||
| Interest Coverage | 2.25 | ||
| Cash Conversion | 123.84% | ||
| Profit Quality | 285.66% | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 3.54 |
F-Score7
WACC7.82%
ROIC/WACC0.56
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
EPS Next Y23.98%
EPS Next 2Y25.51%
EPS Next 3Y24.81%
EPS Next 5Y21.45%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%
Revenue Next Year9.39%
Revenue Next 2Y9.85%
Revenue Next 3Y10.49%
Revenue Next 5Y10.39%
EBIT growth 1Y-0.84%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year91.76%
EBIT Next 3Y37.04%
EBIT Next 5Y27.34%
FCF growth 1Y325.99%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y45.08%
OCF growth 3Y5.11%
OCF growth 5Y21.32%